• About
  • Services
  • Clients
  • Client Media
    • Client News
    • Client Videos
    • CEO Insights
  • PCG Research
  • PCG Digital
    • PCG Digital Tech Watch
    • PCG Digital Biotech Watch
  • Contact
  • follow:

  • 12 Aug

    Soligenix Announces Recent Accomplishments And Second Quarter 2022 Financial Results

    "We have accomplished a number of important milestones thus far in 2022, with more significant milestones anticipated before year-end," stated Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix. "Under our Specialized Biotherapeutics business segment, the results of our successful Phase 3 FLASH (Fluorescent Light Activated Synthetic Hypericin)… Read More..

    Share this:
  • 11 Aug

    Timber Pharmaceuticals Provides Business Update and Announces Second Quarter 2022 Financial Results

    Timber Enrolls First Patients in Phase 3 ASCEND Clinical Trial after Receiving Breakthrough Designation from FDA for Lead Asset TMB-001 BASKING RIDGE, NJ, Aug. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and… Read More..

    Share this:
  • 11 Aug

    Quoin Pharmaceuticals to Report Second Quarter 2022 Financial Results and Provide Corporate Update on August 18th

    ASHBURN, Va., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announced today that its second quarter 2022 financial results will be reported on Thursday, August 18, 2022 before the open of… Read More..

    Share this:
1 2 3 … 44 Next »
  • PCG Advisory GroupFollow

    PCG Advisory Group
    PCGAdvisoryPCG Advisory Group@PCGAdvisory·
    12 Aug

    Reminder: Empire Petroleum (NYSE American: $EP) will report its Q2 2022 financial results and provide a corporate update on Tuesday, August 16, 2022 at 11:00am ET. Access the webcast here: https://t.co/iXttGy34bm
    #StocksInFocus
    Read our disclosures at https://t.co/RU1aW7XYbc

    Reply on Twitter 1558169007274033152Retweet on Twitter 1558169007274033152Like on Twitter 1558169007274033152Twitter 1558169007274033152
    PCGAdvisoryPCG Advisory Group@PCGAdvisory·
    12 Aug

    Soligenix $SNGX Announces Recent Accomplishments And Second Quarter 2022 Financial Results
    #biopharmaceutical #StocksInFocus #financialresults
    #investors #daytrader
    Read our disclosures at https://t.co/RU1aW7XYbc
    https://t.co/qotiquLtZf

    Reply on Twitter 1558151785948368896Retweet on Twitter 1558151785948368896Like on Twitter 15581517859483688961Twitter 1558151785948368896
    PCGAdvisoryPCG Advisory Group@PCGAdvisory·
    11 Aug

    Timber Pharmaceuticals $TMBR Provides Business Update and Announces Second Quarter 2022 Financial Results
    #financialresults #StocksInFocus #investors #daytarder
    Read our disclosures at https://t.co/RU1aW7XYbc
    https://t.co/7GA7OozTWP

    Reply on Twitter 1557857824247529472Retweet on Twitter 1557857824247529472Like on Twitter 1557857824247529472Twitter 1557857824247529472
    Load More...
  • QUICK LINKS

    • About
    • Services
    • Clients
    • Client Media
    • PCG Media
    • PCG Research
    • Contact
    • Privacy Policy
    • Disclosures

    FOLLOW US

    Copyright © 2022 PCG Advisory.

    MENU logo
    • About
    • Services
    • Clients
    • Client Media
      • Client News
      • Client Videos
      • CEO Insights
    • PCG Research
    • PCG Digital
      • PCG Digital Tech Watch
      • PCG Digital Biotech Watch
    • Contact